Retatrutide is a new medication in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these receptors, Retatrutide controls cravings, {promotesinsulin secretion, and ultimately contributes